Medicamen Biotech Limited
₹301.2-1.26%Feb 27, 3:45 PM IST
MEDICAMEQ•Health Technology•Pharmaceuticals: Major
Current Price
₹301.2-1.26%
Feb 27, 3:45 PM ISTMarket Cap₹409.66 Cr
Market Cap₹409.66 Cr
Business Overview
Medicamen Biotech Limited operates through 1 main business divisions including Pharmaceuticals.
Business Hierarchy Structure for Medicamen Biotech Limited
- Medicamen Biotech Limited
- Pharmaceuticals
- Therapeutic Areas
- Oncology
- Cardiovascular
- Diabetology
- General Pain Management
- Hypertension
- Antibiotics
- Cardiology
- Diabetic
- Nutraceutical
- Other Products
- Product Formulations
- Finished Dosage Forms (FDFs)
- Tablets
- Capsules
- Ointments
- Liquid Orals
- Powder for Suspension (Dry Syrups)
- Injectables
- Lyophilized Formulations
- Ready-to-Use (RTU) Formulations
- Oral Solid Dosage Forms
- Iron & Folic Acid tablets
- Active Pharmaceutical Ingredients (APIs)
- Finished Dosage Forms (FDFs)
- Geographical Portfolios
- ROW Portfolio
- Products registered in Ethiopia
- Products registered in Ghana
- Products under registration in Francophone, Africa
- Products registered in Brazil
- Products registered in Equador
- Products registered in Bhutan
- US Portfolio
- Bortezomib Injection 3.5 mg (ANDA filed)
- EU Portfolio
- Products under registration
- Products under filling
- Products developed & filled
- Products under development in R&D
- Australia Portfolio
- Products developed in R&D and ready for filling
- ROW Portfolio
- Therapeutic Areas
- Pharmaceuticals